Relevance of the Application of Pharmacokinetic-pharmacodynamic Modelling Concepts in Drug Development. The "wooden Shoe' Paradigm

Overview

Journal Clin Pharmacokinet

Specialty Pharmacology

Date 1997 Apr 1

PMID 9113436

Citations 26

Authors

D D Breimer

M Danhof

Affiliations

Soon will be listed here.

Citing Articles

Desorption Electrospray Ionization Mass Spectrometry Imaging Allows Spatial Localization of Changes in Acetaminophen Metabolism in the Liver after Intervention with 4-Methylpyrazole.

Akakpo J, Jaeschke M, Etemadi Y, Artigues A, Toerber S, Olivos H J Am Soc Mass Spectrom. 2022; 33(11):2094-2107.

PMID: 36223142 PMC: 9901546. DOI: 10.1021/jasms.2c00202.

Dissecting the Pharmacodynamics and Pharmacokinetics of MSCs to Overcome Limitations in Their Clinical Translation.

Salvadori M, Cesari N, Murgia A, Puccini P, Riccardi B, Dominici M Mol Ther Methods Clin Dev. 2019; 14:1-15.

PMID: 31236426 PMC: 6581775. DOI: 10.1016/j.omtm.2019.05.004.

Pharmacokinetic and Pharmacodynamic Relationship of Blinatumomab in Patients with Non-Hodgkin Lymphoma.

Hijazi Y, Klinger M, Kratzer A, Wu B, Baeuerle P, Kufer P Curr Clin Pharmacol. 2018; 13(1):55-64.

PMID: 29773068 PMC: 6327122. DOI: 10.2174/1574884713666180518102514.

Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects.

Rambiritch V, Naidoo P, Pillai G Clin Pharmacol. 2016; 8:141-153.

PMID: 27713650 PMC: 5044993. DOI: 10.2147/CPAA.S102674.

Sobol Sensitivity Analysis: A Tool to Guide the Development and Evaluation of Systems Pharmacology Models.

Zhang X, Trame M, Lesko L, Schmidt S CPT Pharmacometrics Syst Pharmacol. 2016; 4(2):69-79.

PMID: 27548289 PMC: 5006244. DOI: 10.1002/psp4.6.

References

van Steveninck A, Verver S, Schoemaker H, Pieters M, Kroon R, Breimer D . Effects of temazepam on saccadic eye movements: concentration-effect relationships in individual volunteers. Clin Pharmacol Ther. 1992; 52(4):402-8. DOI: 10.1038/clpt.1992.162. View

Blue J, Colburn W . Efficacy measures: surrogates or clinical outcomes?. J Clin Pharmacol. 1996; 36(9):767-70. DOI: 10.1002/j.1552-4604.1996.tb04249.x. View

Urquhart J . Role of patient compliance in clinical pharmacokinetics. A review of recent research. Clin Pharmacokinet. 1994; 27(3):202-15. DOI: 10.2165/00003088-199427030-00004. View

Yacobi A, Wingard Jr L, Levy G . Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin. J Pharm Sci. 1974; 63(6):868-72. DOI: 10.1002/jps.2600630613. View

Breimer L, Burm A, Danhof M, Hennis P, Vletter A, de Voogt J . Pharmacokinetic-pharmacodynamic modelling of the interaction between flumazenil and midazolam in volunteers by aperiodic EEG analysis. Clin Pharmacokinet. 1991; 20(6):497-508. DOI: 10.2165/00003088-199120060-00006. View

Mandema J, Kuck M, Danhof M . Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship. Br J Pharmacol. 1992; 105(1):164-70. PMC: 1908634. DOI: 10.1111/j.1476-5381.1992.tb14229.x. View

Egan T, Minto C, Hermann D, Barr J, Muir K, Shafer S . Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology. 1996; 84(4):821-33. DOI: 10.1097/00000542-199604000-00009. View

Mathot R, Van den Aarsen B, Soudijn W, Breimer D, IJzerman A, Danhof M . Pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of R- and S-N6-phenylisopropyladenosine in conscious normotensive rats. J Pharmacol Exp Ther. 1995; 273(1):405-14. View

Unadkat J, Bartha F, Sheiner L . Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models. Clin Pharmacol Ther. 1986; 40(1):86-93. DOI: 10.1038/clpt.1986.143. View

10.

Danhof M, Mandema J, Hoogerkamp A, Mathot R . Pharmacokinetic-pharmacodynamic modelling in pre-clinical investigations: principles and perspectives. Eur J Drug Metab Pharmacokinet. 1993; 18(1):41-7. DOI: 10.1007/BF03220007. View

11.

Kleinbloesem C, van Brummelen P, Danhof M, Faber H, Urquhart J, Breimer D . Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. Clin Pharmacol Ther. 1987; 41(1):26-30. DOI: 10.1038/clpt.1987.5. View

12.

Sheiner L, Stanski D, Vozeh S, Miller R, Ham J . Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther. 1979; 25(3):358-71. DOI: 10.1002/cpt1979253358. View

13.

Veng-Pedersen P, Modi N . Pharmacodynamic system analysis of the biophase level predictor and the transduction function. J Pharm Sci. 1992; 81(9):925-34. DOI: 10.1002/jps.2600810918. View

14.

Lieberman R, McMichael J . Role of pharmacokinetic-pharmacodynamic principles in rational and cost-effective drug development. Ther Drug Monit. 1996; 18(4):423-8. DOI: 10.1097/00007691-199608000-00019. View

15.

Jusko W, Ko H . Physiologic indirect response models characterize diverse types of pharmacodynamic effects. Clin Pharmacol Ther. 1994; 56(4):406-19. DOI: 10.1038/clpt.1994.155. View

16.

Dayneka N, Garg V, Jusko W . Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm. 1993; 21(4):457-78. PMC: 4207304. DOI: 10.1007/BF01061691. View

17.

Sheiner L . The intellectual health of clinical drug evaluation. Clin Pharmacol Ther. 1991; 50(1):4-9. DOI: 10.1038/clpt.1991.97. View

18.

Peck C, Barr W, Benet L, Collins J, Desjardins R, Furst D . Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development. Clin Pharmacol Ther. 1992; 51(4):465-73. DOI: 10.1038/clpt.1992.47. View

19.

Dingemanse J, Danhof M, Breimer D . Pharmacokinetic-pharmacodynamic modeling of CNS drug effects: an overview. Pharmacol Ther. 1988; 38(1):1-52. DOI: 10.1016/0163-7258(88)90101-5. View

20.

Kleinbloesem C, van Harten J, Wilson J, Danhof M, van Brummelen P, Breimer D . Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration. Clin Pharmacol Ther. 1986; 40(1):21-8. DOI: 10.1038/clpt.1986.134. View